A large (3900 patients) cohort study, undertaken in five European sites to validate in a
mHealth platform to enable self-management of HIV in patients with stable disease using a
tailored HTA process, Model for Assessment of Telemedicine Applications (MAST), specifically
developed for the assessment of mHealth solutions.
As site recruitment will be sequential and the recruitment period will last 18 months, a
maximum follow-up of 35 Months will be undertaken. Study visits will take place at baseline
defined as the time of mHealth introduction, months 6, 12, 18, 24 and 30.